2017 Cardiotoxicity Mechanism Abstracts

GCOS2017-P2-023

Dual cardioprotection with betablockers and angiotensin converting enzyme inhibitors/angiotensin receptor blockers improves global longitudinal strain before ejection fraction

Presenting Author: Ana Ferreira, Cardiac Physiologist, Barts Heart Centre, Barts Health NHS Trust, London, United Kingdom

 

GCOS2017-P2-024

Checkpoint inhibitor associated myocarditis: Potential for complete recovery with corticosteroids

Presenting Author: Dr. Sarju Ganatra, Fellow, Lahey Hospital & Medical Center, Burlington, MA, USA

 

GCOS2017-P2-025

Effect of androgen deprivation therapy on exercise capacity and cardiovascular mortality in prostate cancer patients referred for exercise treadmill testing

Presenting Author: Dr. John Groarke, Physician, Instructor of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA

 

GCOS2017-P2-026

Effects of an endogenous ligand for ErbB2/ErbB4 receptors on cardiac function and survival in chronic heart failure

Presenting Author: Miss. Jennifer Miao, Medical Student, Vanderbilt University School of Medicine, Nashville, TN, USA

 

GCOS2017-P2-027

Takosubo syndrome in patients with malignancy – clinical characteristic

Presenting Author: Dr. Grzegorz Piotrowski, Head of Cardiology Department, N-Copernicus Memorial Hospital, Lodz, Poland